The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Open accessAbstract
BACKGROUND: Acute respiratory infections (ARIs) comprise a large and heterogeneous group of infections including bacterial, viral and other aetiologies. In recent years, procalcitonin - the prohormone of calcitonin - has emerged as a promising marker for the diagnosis of bacterial infections and for improving decisions about antibiotic therapy. Several randomised controlled trials (RCTs) have demonstrated the feasibility of using procalcitonin for starting and stopping antibiotics in different patient populations with acute respiratory infections and different settings ranging from primary care to emergency departments (EDs), hospital wards and intensive care units (ICUs). OBJECTIVES: The aim of this systematic review based on individual patient data was to assess the safety and efficacy of using procalcitonin for starting or stopping antibiotics over a large range of patients with varying severity of ARIs and from different clinical settings. SEARCH METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL 2011, Issue 2) which contains the Acute Respiratory Infections Group's Specialised Register, MEDLINE (1966 to May 2011) and EMBASE (1974 to May 2011) to identify suitable trials. SELECTION CRITERIA: We included RCTs of adult participants with ARIs who received an antibiotic treatment either based on a procalcitonin algorithm or usual care/guidelines. Trials were excluded if they exclusively focused on paediatric patients or if they used procalcitonin for another purpose than to guide initiation and duration of antibiotic treatment. DATA COLLECTION AND ANALYSIS: Two teams of review authors independently evaluated the methodology and extracted data from primary studies. The primary endpoints were all-cause mortality and treatment failure at 30 days. For the primary care setting, treatment failure was defined as death, hospitalisation, ARI-specific complications, recurrent or worsening infection, and patients reporting any symptoms of an ongoing respiratory infection at follow-up. For the ED setting, treatment failure was defined as death, ICU admission, re-hospitalisation after index hospital discharge, ARI-associated complications, and recurrent or worsening infection within 30 days of follow-up. For the ICU setting, treatment failure was defined as death within 30 days of follow-up. Secondary endpoints were antibiotic use (initiation of antibiotics, duration of antibiotics and total exposure to antibiotics (total amount of antibiotic days divided by total number of patients)), length of hospital stay for hospitalised patients, length of ICU stay for critically ill patients, and number of days with restricted activities within 14 days after randomisation for primary care patients.For the two co-primary endpoints of all-cause mortality and treatment failure, we calculated odds ratios (ORs) and 95% confidence intervals (CIs) using multivariable hierarchical logistic regression. The hierarchical regression model was adjusted for age and clinical diagnosis as fixed-effect. The different trials were added as random-effects into the model. We fitted corresponding linear regression models for antibiotic use. We conducted sensitivity analyses stratified by clinical setting and ARI diagnosis to assess the consistency of our results. MAIN RESULTS: We included 14 trials with 4221 participants. There were 118 deaths in 2085 patients (5.7%) assigned to procalcitonin groups compared to 134 deaths in 2126 control patients (6.3%) (adjusted OR 0.94, 95% CI 0.71 to 1.23). Treatment failure occurred in 398 procalcitonin group patients (19.1%) and in 466 control patients (21.9%). Procalcitonin guidance was not associated with increased mortality or treatment failure in any clinical setting, or ARI diagnosis. These results proved robust in various sensitivity analyses. Total antibiotic exposure was significantly reduced overall (median (interquartile range) from 8 (5 to 12) to 4 (0 to 8) days; adjusted difference in days, -3.47, 95% CI -3.78 to -3.17, and across all the different clinical settings and diagnoses. AUTHORS' CONCLUSIONS: Use of procalcitonin to guide initiation and duration of antibiotic treatment in patients with ARI was not associated with higher mortality rates or treatment failure. Antibiotic consumption was significantly reduced across different clinical settings and ARI diagnoses. Further high-quality research is needed to confirm the safety of this approach for non-European countries and patients in intensive care. Moreover, future studies should also establish cost-effectiveness by considering country-specific costs of procalcitonin measurement and potential savings in consumption of antibiotics and other healthcare resources, as well as secondary cost savings due to lower risk of side effects and reduced antimicrobial resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
Goossens, H., Ferech, M., Vander Stichele, R., & Elseviers, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17907-0 · Cited by 3,359
Simon, L., Gauvin, F., Amre, D. K., Saint-Louis, P., & Lacroix, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421997 · Cited by 1,787
Kumar, A., Ellis, P., Arabi, Y., Roberts, D., Light, B., Parrillo, J. E., Dodek, P., Wood, G., Kumar, A., Simon, D., et al. (2009) · Chest · doi:10.1378/chest.09-0087 · Cited by 1,187
Bouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183
Self-citationChrist-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M. M., Huber, P. R., Tamm, M., & Müller, B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15591-8 · Cited by 1,096
Self-citationSchuetz, P., Christ-Crain, M., Thomann, R., Falconnier, C., Wolbers, M., Widmer, I., Neidert, S., Fricker, T., Blum, C., Schild, U., et al. (2009) · JAMA · doi:10.1001/jama.2009.1297 · Cited by 959
Self-citationProcalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia: A Randomized Trial
Christ-Crain, M., Stolz, D., Bingisser, R., Müller, C., Miedinger, D., Huber, P. R., Zimmerli, W., Harbarth, S., Tamm, M., & Müller, B. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200512-1922oc · Cited by 884
Self-citationTang, B. M., Eslick, G. D., Craig, J. C., & McLean, A. S. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70052-x · Cited by 851
Uzzan, B., Cohen, R., Nicolas, P., Cucherat, M., & Perret, G.-Y. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000226413.54364.36 · Cited by 738
Gonzales, R. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550110039033 · Cited by 717
Interventions to improve antibiotic prescribing practices in ambulatory care
Arnold, S. R., & Straus, S. E. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003539.pub2 · Cited by 713
Roberts, R. R., Hota, B., Ahmad, I., Scott II, R. D., Foster, S. D., Abbasi, F., Schabowski, S., Kampe, L. M., Ciavarella, G. G., Supino, M., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/605630 · Cited by 705
Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit
Müller, B., Becker, K. L., Schächinger, H., Rickenbacher, P. R., Huber, P. R., Zimmerli, W., & Ritz, R. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004000-00011 · Cited by 628
Self-citationUse of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients
Nobre, V., Harbarth, S., Graf, J.-D., Rohner, P., & Pugin, J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1238oc · Cited by 605
Simmonds, M. C., Higginsa, J. P. T., Stewartb, L. A., Tierneyb, J. F., Clarke, M. J., & Thompson, S. G. (2005) · Clinical Trials · doi:10.1191/1740774505cn087oa · Cited by 555
Antibiotic Treatment of Exacerbations of COPD
Stolz, D., Christ-Crain, M., Bingisser, R., Leuppi, J., Miedinger, D., Müller, C., Huber, P., Müller, B., & Tamm, M. (2007) · Chest · doi:10.1378/chest.06-1500 · Cited by 521
Self-citationCals, J. W. L., Butler, C. C., Hopstaken, R. M., Hood, K., & Dinant, G.-J. (2009) · BMJ · doi:10.1136/bmj.b1374 · Cited by 498
Macfarlane, J. T., Macfarlane, R. M., Rose, D. H., Colville, A., & Guion, A. (1993) · The Lancet · doi:10.1016/0140-6736(93)90275-l · Cited by 399
Schuetz, P. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.318 · Cited by 386
Self-citationOpen randomised trial of prescribing strategies in managing sore throat
Little, P., Williamson, I., Warner, G., Gould, C., Gantley, M., & Kinmonth, A. L. (1997) · BMJ · doi:10.1136/bmj.314.7082.722 · Cited by 364
Jensen, J. U., Hein, L., Lundgren, B., Bestle, M. H., Mohr, T. T., Andersen, M. H., Thornberg, K. J., Løken, J., Steensen, M., Fox, Z., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821e8791 · Cited by 356
Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study
Stolz, D., Smyrnios, N., Eggimann, P., Pargger, H., Thakkar, N., Siegemund, M., Marsch, S., Azzola, A., Rakic, J., Mueller, B., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00053209 · Cited by 327
Self-citationBriel, M., Schuetz, P., Mueller, B., Young, J., Schild, U., Nusbaumer, C., Périat, P., Bucher, H. C., & Christ-Crain, M. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.18.2000 · Cited by 321
Self-citationHochreiter, M., Köhler, T., Schweiger, A. M., Keck, F. S., Bein, B., von Spiegel, T., & Schroeder, S. (2009) · Critical Care · doi:10.1186/cc7903 · Cited by 315
Konstantinides, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0804570 · Cited by 270
A multilevel model framework for meta-analysis of clinical trials with binary outcomes
Turner, R. M., Omar, R. Z., Yang, M., Goldstein, H., & Thompson, S. G. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20001230)19:24<3417::aid-sim614>3.0.co;2-l · Cited by 265
Procalcitonin Levels Predict Bacteremia in Patients With Community-Acquired Pneumonia
Müller, F., Christ-Crain, M., Bregenzer, T., Krause, M., Zimmerli, W., Mueller, B., & Schuetz, P. (2010) · Chest · doi:10.1378/chest.09-2920 · Cited by 259
Self-citationSchroeder, S., Hochreiter, M., Koehler, T., Schweiger, A.-M., Bein, B., Keck, F. S., & von Spiegel, T. (2009) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-008-0432-1 · Cited by 238
Procalcitonin Test in the Diagnosis of Bacteremia: A Meta-analysis
Jones, A. E., Fiechtl, J. F., Brown, M. D., Ballew, J. J., & Kline, J. A. (2007) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.10.020 · Cited by 227
Delayed antibiotics for respiratory infections
Spurling, G. K., Del Mar, C. B., Dooley, L., & Foxlee, R. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004417.pub3 · Cited by 226
Heyland, D. K., Johnson, A. P., Reynolds, S. C., & Muscedere, J. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821201a5 · Cited by 213
D'Amico, R., Pifferi, S., Torri, V., Brazzi, L., Parmelli, E., & Liberati, A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000022.pub3 · Cited by 190
Filippini, M., Masiero, G., & Moschetti, K. (2006) · Health Policy · doi:10.1016/j.healthpol.2005.09.009 · Cited by 172
Procalcitonin: How a hormone became a marker and mediator of sepsis
Becker, K. (2001) · Swiss Medical Weekly · doi:10.4414/smw.2001.09751 · Cited by 170
Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection
Burkhardt, O., Ewig, S., Haagen, U., Giersdorf, S., Hartmann, O., Wegscheider, K., Hummers-Pradier, E., & Welte, T. (2010) · European Respiratory Journal · doi:10.1183/09031936.00163309 · Cited by 160
Self-citationProcalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia
Esposito, S., Tagliabue, C., Picciolli, I., Semino, M., Sabatini, C., Consolo, S., Bosis, S., Pinzani, R., & Principi, N. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.09.003 · Cited by 159
Procalcitonin for guidance of antibiotic therapy
Schüetz, P., Albrich, W. C., Christ‐Crain, M., Chastre, J. E., & Müeller, B. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.25 · Cited by 158
Self-citationStocker, M., Fontana, M. S., el Helou, S., Wegscheider, K., & Berger, T. M. (2009) · Neonatology · doi:10.1159/000241296 · Cited by 154
Economic costs of respiratory tract infections in the United States
Dixon, R. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90363-8 · Cited by 148
Kristoffersen, K. B., Søgaard, O. S., Wejse, C. M., Black, F. T., Greve, T., Tarp, B., Storgaard, M., & Sodemann, M. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02709.x · Cited by 133
Self-citationAzithromycin for acute bronchitis: a randomised, double-blind, controlled trial
Evans, A. T., Husain, S., Durairaj, L., Sadowski, L. S., Charles‐Damte, M., & Wang, Y. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08597-5 · Cited by 124
Tang, H., Huang, T., Jing, J.-M., Shen, H., & Cui, W. (2009) · Infection · doi:10.1007/s15010-009-9034-2 · Cited by 110
Antimicrobial Stewardship in the Intensive Care Unit
Lawrence, K., & Kollef, M. H. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1394cp · Cited by 108
Classen, D. C., Jaser, L., & Budnitz, D. S. (2010) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(10)36003-x · Cited by 106
Multilevel models for meta-analysis, and their application to absolute risk differences
Thompson, S. G., Turner, R., & Warn, D. E. (2001) · Statistical Methods in Medical Research · doi:10.1177/096228020101000602 · Cited by 102
Long, W., Deng, X., Zhang, Y., Lü, G., Xie, J., & Tang, J. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.01978.x · Cited by 97
Schüetz, P., Batschwaroff, M., Dusemund, F., Albrich, W. C., Bürgi, U., Maurer, M., Brutsche, M. H., Huber, A., & Müller, B. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0851-0 · Cited by 64
Self-citationQu, R., Ji, Y., Ling, Y., Ye, C.-Y., Yang, S.-M., Liu, Y.-Y., Yang, R.-Y., Luo, Y.-F., & Guo, Z. (2012) · Saudi Medical Journal · doi:10.15537/1658-3175.5525 · Cited by 46
Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department
Doan, Q. H., Enarson, P., Kissoon, N. “., Klassen, T. P., & Johnson, D. W. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006452.pub3 · Cited by 39
Saeed, K. B. A., Dryden, M., Bourne, S., Paget, C., & Proud, A. (2011) · Journal of Hospital Infection · doi:10.1016/j.jhin.2011.03.018 · Cited by 36
Liew, Y. X., Chlebicki, M. P., Lee, W., Hsu, L. Y., & Kwa, A. L. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1165-6 · Cited by 35
Maravić-Stojkovic, V., Lausević-Vuk, L., Jovic, M. D., Rankovic, A., Borzanovic, M. D., & Marinković, J. (2011) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh1112736m · Cited by 32
Cited by
Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1581st · Cited by 3,657
Understanding the mechanisms and drivers of antimicrobial resistance
Holmes, A. H., Moore, L. S. P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., Guerin, P. J., & Piddock, L. J. V. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00473-0 · Cited by 2,611
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00214-2017 · Cited by 881
Metadata
- Authors
- Schuetz, P., Müller, B., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., Tubach, F., Kristoffersen, K. B., Burkhardt, O., Welte, T., Schroeder, S., Nobre, V., Wei, L., Bhatnagar, N., Bucher, H. C., & Briel, M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2012-09-12
- Issue
- 9
- Pages
- CD007498-CD007498
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W4238786993
- Cited by
- 264
- References
- 55
- Type
- reference entry
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.